KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis.

Cancer Sci · 2025-Jun · PMID 40099663

Panel TFST提取完成待 EXE 对齐验证

time to first subsequent therapy

FIGURE 3 Kaplan–Meier estimate curves for TFST in the Asian subset (DCO: 12 October 2022). A circle indicates a censored observation. HR and CIs were calculated using a Cox proportional hazards model adjusted for the variables selected in the primary pooling strategy: metastases and docetaxel treatment at mHSPC stage. CI, confidence interval; DCO, data cutoff; HR, hazard ratio; mHSPC, metastatic hormone‐sensitive prostate cancer; NC, not calculable; TFST, time to first subsequent therapy.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-18T20:11:27+00:00